Digoxin and Platelet Activation in Patients With Atrial Fibrillation: In Vivo and In Vitro Study

BACKGROUND: Digoxin use was shown to be associated with an increased risk of cardiovascular events in atrial fibrillation (AF). We hypothesized that digoxin may affect cardiovascular risk by increasing platelet activation. METHODS AND RESULTS: Post hoc analysis of a prospective study of anticoagulat...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Am Heart Assoc
Glavni autori: Pastori, Daniele, Carnevale, Roberto, Nocella, Cristina, Bartimoccia, Simona, Novo, Marta, Cammisotto, Vittoria, Piconese, Silvia, Santulli, Maria, Vasaturo, Fortunata, Violi, Francesco, Pignatelli, Pasquale
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2018
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6404445/
https://ncbi.nlm.nih.gov/pubmed/30571484
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.118.009509
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items